Movano (NASDAQ:MOVE) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Movano (NASDAQ:MOVEFree Report) to a hold rating in a report issued on Saturday.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Read Our Latest Analysis on MOVE

Movano Stock Performance

NASDAQ:MOVE opened at $8.39 on Friday. Movano has a one year low of $4.67 and a one year high of $62.80. The stock has a market cap of $6.96 million, a PE ratio of -0.77 and a beta of 0.77. The stock has a 50 day moving average price of $8.47 and a 200 day moving average price of $7.46.

Movano (NASDAQ:MOVEGet Free Report) last released its quarterly earnings data on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating analysts’ consensus estimates of ($7.00) by $2.27. The firm had revenue of $0.08 million for the quarter, compared to analysts’ expectations of $3.88 million. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.

Institutional Investors Weigh In On Movano

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Baird Financial Group Inc. boosted its holdings in shares of Movano by 3.6% in the first quarter. Baird Financial Group Inc. now owns 323,943 shares of the technology company’s stock valued at $593,000 after acquiring an additional 11,366 shares during the period. Clayton Partners LLC raised its position in Movano by 27.2% in the 1st quarter. Clayton Partners LLC now owns 143,476 shares of the technology company’s stock valued at $263,000 after purchasing an additional 30,708 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new stake in Movano during the 3rd quarter worth $28,000. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Key Stores Impacting Movano

Here are the key news stories impacting Movano this week:

  • Positive Sentiment: Shareholders approved key amendments and initiatives at the recent meeting, removing a source of corporate uncertainty and enabling planned corporate actions (capital-structure or governance changes). Investors often view such approvals as clearing the way for financings or restructurings that can stabilize a micro-cap name. Movano stockholders approve key amendments and initiatives
  • Neutral Sentiment: Recent analyst / media write-ups are re-examining Movano’s outlook vs. peers, highlighting valuation and business-model questions but not issuing widespread upgrades — coverage that can attract attention but is unlikely on its own to sustain a rally. Analyzing Movano (NASDAQ:MOVE) and Health Catalyst (NASDAQ:HCAT)
  • Negative Sentiment: Fundamentals remain challenging: recent quarterly results showed a smaller-than-expected EPS loss relative to estimates but revenue was extremely low and the company continues to report large operating losses and negative margins — factors that keep upside speculative until revenue and cash-flow trajectories improve.
  • Negative Sentiment: Market structure risk — Movano has a very small market capitalization, low average daily volume and a wide range between its 52-week low and high. That combination makes the stock prone to outsized moves on limited news or low-volume trades, increasing short-term volatility and execution risk for investors.

Movano Company Profile

(Get Free Report)

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.

Featured Stories

Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.